Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children

Vaccine

Volumn 22, Issue 31-32, 2004, Pages 4262-4269

  Collins, C L ^a   Salt, P ^a   McCarthy, N ^a   Chantler, T ^a   Lane, L ^a   Hemme, F ^b   Diggle, L ^a   Buttery, J ^a   Kitchin, N R E ^b   Moxon, E R ^a   Pollard, A J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UK   (United Kingdom)

Author keywords

Immunogenicity and safety; Low dose diphtheria vaccine; Pre school booster

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; INACTIVATED VACCINE; M M R; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG DOSE REGIMEN; DRUG SAFETY; HUMAN; IMMUNOGENICITY; PERTUSSIS; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TETANUS; UNITED KINGDOM;

ANTITOXINS; CHILD, PRESCHOOL; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GREAT BRITAIN; HUMANS; IMMUNIZATION, SECONDARY; MALE; PATIENT COMPLIANCE; POLIOVIRUS VACCINES; SAMPLE SIZE; TETANUS; VACCINES, COMBINED;

EID: 4944225305     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.027     Document Type: Article

References (16)

1. J. Lewis The prevention of diphtheria in Canada and Britain, 1914-1945 J. Social Hist. 20 1986 163 176
2. A. Galazka The changing epidemiology of diphtheria in the vaccine era J. Infect. Dis. 181 Suppl. 1 2000 S2 S9
3. Immunisation against infectious disease 1996 HM Stationary Office London
4. L. Terry The association of cases of poliomyelitis with the use of type 3 oral poliomyelitis vaccines 1962 US Department of Health, Education and Welfare Washington, DC
5. A.M. Galazka The immunological basis for immunization series Module 2: diphtheria 2001 World Health Organisation Geneva [WHO/EPI/93.12]
6. A.M. Galazka The immunological basis for immunization series Module 3: tetanus 2001 World Health Organisation Geneva [WHO/EPI/GEN/93.13]
7. R.A. Fisher Statistical methods for research workers 5th ed. 1934 Oliver and Boyd Edinburgh
8. M. Burrage, A. Robinson, R. Borrow, N. Andrews, J. Southern, and J. Findlow Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection Infect. Immun. 70 9 2002 4946 4954
9. E. Miller, P. Waight, H. Laurichesse, N. Andrews, C. Thornton, and D. Sesardic Immunogenicity and reactogenicity of acellular diphtheria/tetanus/ pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR Vaccine 19 2001 3904 3911
10. F. Zepp, B. Cheuvart, and J.M. Wolter Anti-diphtheria antibodies should persist until adolescence after a reduced-antigen diphtheria, tetanus and acellular pertussis vaccine (DTPA) in pre-school-aged children Proceedings of the 21st Annual Meeting of the European Society of Pediatric Infectious Disease Sicily 2003
11. S.A. Halperin, B. Smith, M. Russell, D. Scheifele, E. Mills, and P. Hasselback Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults Pediatr. Infect. Dis. J. 19 2000 276 283
12. L.D. Senzilet, S.A. Halperin, J.S. Spika, M. Alagaratnam, A. Morris, and B. Smith Pertussis is a frequent cause of prolonged cough illness in adults and adolescents Clin. Infect. Dis. 32 12 2001 1691 1697
13. P. Olin, F. Rasmussen, L. Gustafsson, H.O. Hallander, and H. Heijbel Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine Ad Hoc Group for the Study of Pertussis Vaccines Lancet 350 1997 1569 1577
14. L. Gustafsson, H.O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine N. Engl. J. Med. 334 1996 349 355
15. I. Scheibel, S. Tulinius, G. Rasch, K. Bojlen, and C.B. Petersen Immunization of adults against diphtheria with particular reference to dosage and reactions Acta Pathol. Microbiol. Immunol. Scand. 1947 319 350
16. J. McVernon, J. MacLennan, E. Clutterbuck, J. Buttery, and E.R. Moxon Effect of infant immunisation with meningococcus serogroup C-CRM(197) conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children Vaccine 21 19-20 2003 2573 2579